Who Owns Pfizer - Search News

Pfizer to Acquire Obesity Drug Start-Up Metsera

Digest more

· 3d

Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal

Pfizer will acquire Metsera at a price of up to $86.25 a share, Metsera said in a statement.

· 3d

Pfizer Clinches Deal for Obesity Drug Developer Metsea After a Bidding War With Novo Nordisk

· 3d · on MSN

Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition

· 21h

Pfizer Wins Obesity War Against NVO, to Buy Metsera for Around $10B

The heated bidding war between Pfizer PFE and Danish rival, Novo Nordisk NVO, related to the proposed acquisition of obesity drug developer Metsera MTSR is finally over.

· 1d

Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.

· 1d

Pfizer wins bidding war for obesity drug startup

Novo, Pfizer Are Battling To Buy The Future Of Weight-Loss — But Viking Already Owns It

Viking Global's $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo Nordisk.

Axios on MSN

Novo and Pfizer make their America First case in their fight over an anti-obesity biotech

Novo Nordisk and Pfizer's multibillion-dollar fight over who gets to buy an anti-obesity biotech has morphed into a narrative argument over which acquisition would be most America First — a framing with clear political implications.

11d

Pfizer could hold a Trump card in its bid for Metsera

U.S. drugmaker Pfizer could work its connections within President Donald Trump's administration to try to thwart Novo Nordisk's surprise rival bid to acquire U.S. obesity biotech firm Metsera, analysts,